Equity Research, Broker Reports, and media content on MaxCyte, Inc.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MaxCyte, Inc.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

MaxCyte, Inc.

Company Profile

  • Personnel
  • Doug Doerfler , CEO
  • Ron Holtz, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MaxCyte, Inc.. We currently have 78 research reports from 6 professional analysts.

  • Open: 690p
  • Range Today: 680/705p
  • 52 Week: 116/700p
  • Daily Volume: 6.1k
  • Daily Liquidity: (0.01%)
  • # Shares: 61.3m
  • Market Cap: £533.4m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
21Jan21 14:49 RNS Increase to Block Listing
20Jan21 07:00 RNS Trading Update
11Jan21 07:00 RNS Myeloid Therapeutics Clinical & Commercial License
23Dec20 07:00 RNS Trading Update
09Nov20 13:00 RNS CARMA Cell Therapies at SITC 2020
09Nov20 07:00 RNS Presentations at Upcoming Virtual IR Conferences
02Nov20 15:52 RNS Result of AGM
  • Frequency of research reports


  • Research reports on

    MaxCyte, Inc.

  • Providers covering

    MaxCyte, Inc.